I called attention to the large blocks that keep going off at the ask, because they suggest someone is accumulating. Daily golden cross should follow the weekly, thanks for pointing it out.
It's not a lot of money for some to buy 100K shares at this low share price, but I guess the prospect that a partnership might be in the works is frightening enough to provide grist for the mill for ridiculing everything about the company, including the CEO and his "salary." A tired argument used against many OTC companies.
All while NIAID and NIH continue to research Brilacidin for 20+ indications and counting.
And there aren't many good alternatives for severe OM that B has been shown to help in a successful PH-2 clinical trial.
News 
Market Data 
Discover 
